OTCMKTS:NBHGF Nobel Biocare (NBHGF) Stock Price, News & Analysis → Musk’s new company could top a trillion? (From Paradigm Press) (Ad) Free NBHGF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$18.25▼$18.2550-Day Range N/A52-Week Range$16.35▼$19.50VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nobel Biocare alerts: Email Address Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> About Nobel BiocareRead More Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> NBHGF Stock News HeadlinesDecember 19, 2023 | bbc.comNobel Peace Prize: Journalists Maria Ressa and Dmitry Muratov share awardDecember 17, 2023 | bbc.comNobel Prize goes to scientists behind mRNA Covid vaccinesJune 18, 2024 | Weiss Ratings (Ad)[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.December 16, 2023 | bbc.comFirst woman Physics Nobel winner in 55 yearsNovember 9, 2023 | forbes.comWill There Be A Nobel Prize For AI?October 18, 2023 | nypost.comNobel Prize winner, 64, calls his parents to tell them he won prestigious award in heartwarming momentOctober 17, 2023 | washingtonpost.comThis couple just published a Nobel winner from their living roomOctober 11, 2023 | theguardian.comNobel laureate urges Polish opposition to commit to progressive causesJune 18, 2024 | Weiss Ratings (Ad)[Urgent] Your ESG score is hereDid you know you probably already have an ESG score? As we speak, the powers that be are building a full-scale social credit system … And soon, it could be used to control the way you live your life.October 3, 2023 | nytimes.comWhat to Know About the 2023 Nobel PrizesJune 14, 2023 | theguardian.com‘If it’s not a risk… it’s nothing’: Nobel laureate Annie Ernaux on her unapologetic careerMay 29, 2023 | washingtonpost.comRobert E. Lucas Jr., Nobel Prize-winning economist, dies at 85April 19, 2023 | forbes.comCreative Inspiration From A Nobel Prize Winner: Bob DylanApril 11, 2023 | thetimes.co.ukAI could hasten the four-day week, says Nobel laureateApril 8, 2023 | latimes.comChatGPT opens door to four-day week, Nobel Prize winner saysMarch 17, 2023 | markets.businessinsider.comNobel laureate Paul Krugman says bailing out SVB was sensible but annoying - and calls for tougher rules to prevent more bank failuresMarch 17, 2023 | bbc.co.ukNobel scientist says 'UK research is in jeopardy'March 16, 2023 | washingtonpost.comKenzaburo Oe, lyrical novelist and Nobel laureate, dies at 88March 11, 2023 | thestreet.comNobel Economist Krugman Calls Out VenmoMarch 7, 2023 | abcnews.go.comBelarus court jails Nobel laureate Bialiatski for 10 yearsMarch 1, 2023 | news.yahoo.comOrlando advocacy group nominated for Nobel Peace PrizeFebruary 20, 2023 | theglobeandmail.comChildren’s rights advocate Landon Pearson was nominated for a Nobel Peace PrizeFebruary 18, 2023 | news.yahoo.comUkrainian Nobel winner demands justice for Russian 'war criminals'January 20, 2023 | theguardian.comSvante Pääbo: ‘It’s maybe time to rethink our idea of Neanderthals’January 5, 2023 | theguardian.comNobel-nominated vaccine expert warns of Covid complacency: ‘We’re still losing too many lives’January 4, 2023 | marketwatch.comBioinert Ceramic Market Growth and Global Share 2023 | Developing Regions, Emerging Trends and Industry Size Forecast to 2029November 16, 2022 | theguardian.comNobel peace laureate Maria Ressa: ‘In 2024, democracy could fall off a cliff’See More Headlines Receive NBHGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nobel Biocare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/21/2014Today6/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dental Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:NBHGF CUSIPN/A CIKN/A Webwww.nobelbiocare.com Phone41-43-211-4200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.01 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key CompetitorsAmerican Medical TechnologiesOTCMKTS:ADLILancer OrthodonticsOTCMKTS:LANZSartorius AktiengesellschaftOTCMKTS:SARTFStraumannOTCMKTS:SAUHYDENTSPLY SIRONANASDAQ:XRAYView All Competitors NBHGF Stock Analysis - Frequently Asked Questions How were Nobel Biocare's earnings last quarter? Nobel Biocare Ag (OTCMKTS:NBHGF) issued its earnings results on Thursday, August, 21st. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.05. The business had revenue of $191.67 million for the quarter, compared to the consensus estimate of $171.79 million. This page (OTCMKTS:NBHGF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nobel Biocare Ag Please log in to your account or sign up in order to add this asset to your watchlist. Share Nobel Biocare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.